OWD
AGN

Osborn Williams & Donohoe’s Allergan plc AGN Stock Holding History

Osborn Williams & Donohoe’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,917
Closed -$278K – 734
2019
Q1 		$278K Hold
1,917
– – 0.03% 308
2018
Q4 		$256K Hold
1,917
– – 0.05% 195
2018
Q3 		$365K Buy
1,917
+15
+0.8% +$2.76K 0.06% 191
2018
Q2 		$317K Buy
1,902
+700
+58% +$112K 0.05% 200
2018
Q1 		$202K Buy
+1,202
New +$202K 0.03% 218

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Osborn Williams & Donohoe's AGN Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,917 shares — an estimated $278K sold.

Osborn Williams & Donohoe first reported a position in AGN in Q1 2018 and held it in 5 quarters. The position peaked at $365K in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 1,917 Allergan plc shares in Q2 2019, an estimated $278K.
  • Osborn Williams & Donohoe first reported a position in Allergan plc in Q1 2018 and held it in 5 quarters.
  • Osborn Williams & Donohoe's Allergan plc position peaked at $365K in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.